Novo Nordisk issued FDA warning letter over adverse event reporting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 39.26 -0.09 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.35 | 52 Week High | $59.00 | |||
| Open | $39.25 | 52 Week Low | $32.80 | |||
| Day High | $39.49 | P/E | N/A | |||
| Day Low | $39.08 | EPS | $0.00 | |||
| Volume | 3,982,709 | |||||
